Skip to content

We are dong this study to find out if warts over skin will get treated faster and better by repeatedly puncturing a wart or by giving Mumps Measles Rubella vaccine for treating multiple skin warts.

Efficacy of Therapeutic Needling versus Intralesional Mumps Measles Rubella vaccine in the treatment of Multiple Cutaneous Warts: a randomized controlled trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/08/073007
Enrollment
72
Registered
2024-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B09- Unspecified viral infection characterized by skin and mucous membrane lesions

Interventions

Intervention1: Therapeutic Needling: Therapeutic Needling is a technique based on Falknors Needling where after administering a local anesthetic agent into a cutaneous wart, it will be followed by rep

Sponsors

Dr Prachi Tete
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients with multiple cutaneous warts (more than equal to 3) 2) Patients presenting to the outpatient department of Dermatology 2) Patients who agree to give informed, written consent

Exclusion criteria

Exclusion criteria: 1) Pregnant and lactating ladies 2) Those with uncontrolled urticaria 3) Hypersensitivity to lignocaine 4) History of uncontrolled asthma 5) History of severe hypersensitivity to vaccines 6) Acute febrile illness 7) Bleeding diathesis 8) Those receiving concomitant other treatments for warts 9) Immunosuppressed patients with Human Immunodeficiency Virus infection, diabetes, post-splenectomy patient or patients on immunosuppressive drugs like corticosteroids 10) Past history of meningitis or convulsions 11) Patients with isolated filiform, plane, genital warts.

Design outcomes

Primary

MeasureTime frame
Resolution rate of cutaneous warts by number of warts cleared Complete clearance of warts Partial clearance of warts No improvement of warts Timepoint: Number of cutaneous warts at 0, 2, 4 and 8 weeks

Secondary

MeasureTime frame
Adverse effects with the proceduresTimepoint: At 0, 2, 4 and 8 weeks.

Countries

India

Contacts

Public ContactDr. Prachi Tete

Department of Dermatology in All India Institute Of Medical Sciences Raipur

satyakiganguly@yahoo.co.in7639471456

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026